GRP78 is frequently overexpressed in refractory tumors and research has pointed to the activation of the pro-survival mechanism and GRP78 upregulation as being a significant contributing factor in the development of antiestrogen-induced resistance in cancer cells. Here, HSPA5 is linked to cancer.